Fluticasone propionate
- Generic Name
- Fluticasone propionate
- Brand Names
- Advair, Airduo, Airduo Respiclick, Aller-flo, Armonair, Beser, Cutivate, Dymista, Flonase, Flovent, Fluticare, Ticanase, Wixela, Xhance
- Drug Type
- Small Molecule
- Chemical Formula
- C25H31F3O5S
- CAS Number
- 80474-14-2
- Unique Ingredient Identifier
- O2GMZ0LF5W
- Background
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
- Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
- Associated Conditions
- Allergic Rhinitis (AR), Allergy to Animal Dander, Allergy to Mold, Allergy to Tree Pollen, Asthma, Bacterial Sinusitis, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Chronic Sinusitis, Dermatitis, Emphysema, Eosinophilic Esophagitis, House Dust Mite Allergy, House dust allergy, Itching of the nose, Nasal Congestion, Non-Allergic Rhinitis, Rhinitis, Rhinitis Perennial, Rhinorrhoea, Seasonal Allergic Rhinitis, Sneezing, Moderate, severe Perennial Allergic Rhinitis (PAR), Moderate, severe Seasonal Allergic Rhinitis
- Associated Therapies
- -
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
- Conditions
- Interventions
- First Posted Date
- 2006-11-29
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 45
- Registration Number
- NCT00404586
- Locations
- 🇩🇪
GSK Investigational Site, Hannover, Niedersachsen, Germany
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Dey
- Target Recruit Count
- 457
- Registration Number
- NCT00403286
- Locations
- 🇺🇸
Research Site, Milwaukee, Wisconsin, United States
Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2006-11-17
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Research Consult GmbH
- Target Recruit Count
- 41
- Registration Number
- NCT00400998
- Locations
- 🇦🇹
GSK Investigational Site, Vienna, Austria
Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
- First Posted Date
- 2006-11-17
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 49
- Registration Number
- NCT00400855
- Locations
- 🇳🇿
GSK Investigational Site, Wellington, New Zealand
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
- Conditions
- Interventions
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 182
- Registration Number
- NCT00395304
- Locations
- 🇺🇸
Kaiser Permanente Medical Center, San Diego, California, United States
🇺🇸National Jewish Medical and Research Center, Denver, Colorado, United States
🇺🇸University of Wisconsin - Madison, Madison, Wisconsin, United States
Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)
- Conditions
- Interventions
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT00387036
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
- Conditions
- Interventions
- First Posted Date
- 2006-07-19
- Last Posted Date
- 2018-05-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 506
- Registration Number
- NCT00353873
- Locations
- 🇸🇪
GSK Investigational Site, Stockholm, Sweden
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2008-10-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 48
- Registration Number
- NCT00348361
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
- Conditions
- Interventions
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT00318708
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸National Jewish Medical and Research Center, Denver, Colorado, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Viapaed Study In Children And Adolescents With Asthma
- Conditions
- Interventions
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 285
- Registration Number
- NCT00315744
- Locations
- 🇩🇪
GSK Investigational Site, Hamburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.